Japanese Chemicals Stock News

Sumitomo Metal Mining (TSE:5713) has announced plans to boost capital in its subsidiary SMM PERTH PTY LTD. This move paves the way for a 30% stake in the Winu copper-gold project held by a Rio Tinto affiliate. See our latest analysis for Sumitomo Metal Mining. Momentum around Sumitomo Metal Mining has picked up impressively, with a 50.9% 90-day share price return suggesting renewed optimism following its latest resource expansion push. Over the past year, the company delivered a solid 25.7%...

Mitsubishi Estate Logistics REIT Investment (TSE:3481) made waves with its latest earnings guidance for fiscal 2026, along with a sharply reduced distribution forecast for February that is certain to catch investors’ attention. See our latest analysis for Mitsubishi Estate Logistics REIT Investment. News of sharply lower distribution guidance for early 2026 comes as Mitsubishi Estate Logistics REIT Investment has quietly regained some momentum. The stock has seen a 6.9% share price return...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Key Insights Institutions' substantial holdings in BANDAI NAMCO Holdings implies that they have significant influence...

Earlier this month, Renesas Electronics introduced its RA8M2 and RA8D2 microcontroller groups, featuring 1 GHz Arm Cortex-M85 processors and advanced graphics capabilities aimed at demanding compute, AI, and industrial networking applications. This launch highlights Renesas’ push into high-performance and energy-efficient microcontrollers, positioning the company to serve complex digital and industrial markets with next-generation embedded processing and graphics solutions. We’ll explore how...

Ono Pharmaceutical recently presented two-year efficacy and safety data from the MOTION Phase 3 study of vimseltinib in patients with tenosynovial giant cell tumor (TGCT) ineligible for surgery at the 2025 European Society for Medical Oncology Congress in Berlin. The long-term results underscore vimseltinib’s potential as a treatment option for individuals with limited alternatives, marking an important achievement in Ono's oncology pipeline. We’ll explore how these positive long-term...

On October 15, 2025, PDRadiopharma Inc., PeptiDream Inc., and Curium Group announced the initiation of a registrational Phase 2 trial in Japan for 64Cu-PSMA-I&T, an innovative PET radiopharmaceutical imaging agent targeting prostate-specific membrane antigen in prostate cancer. This development strengthens the collaborative pipeline for advanced prostate cancer diagnostics and highlights increasing industry attention toward radiopharmaceuticals with both diagnostic and therapeutic...

NEC Corporation recently launched a digital agriculture initiative with Cote d'Ivoire's Ministry of Agriculture, utilizing its e-Voucher and CropScope ICT platform for efficient, transparent management of farming resources and crop monitoring. This collaboration reflects NEC's growing engagement in public-private partnerships and diversification into global sustainability and digital transformation projects across multiple sectors. We'll examine how NEC's expansion into digital agriculture...

On October 16, 2025, Nomura Real Estate Master Fund announced lower distribution per unit for the coming periods and issued new earnings guidance, including an expected distribution of ¥3,124 per unit for both the periods ending February and August 2026, down from the previous year's payouts. This combination of reduced forecasted distributions and moderated profit expectations signals potential challenges in sustaining previous levels of investor returns. We’ll explore how the anticipated...

Takashimaya Company (TSE:8233) has drawn investor attention this week after announcing a series of significant updates. These include revised financial guidance, a new dividend outlook, and the decision to close and sell its Rakusai Store property. See our latest analysis for Takashimaya Company. This run of announcements, from the Rakusai Store closure and property sale to a new dividend forecast and refreshed sales figures, has likely contributed to Takashimaya's strong share price...

If you are considering what to do with your ZOZO shares right now, you are not alone. Investors are taking a close look at this Japanese e-commerce leader after a stretch of uneven performance. There is no denying the excitement around ZOZO’s longer-term record, with the stock up 70.1% over the last five years and climbing 40.4% over three. However, more recent returns have been less inspiring. Over the past year, ZOZO’s share price has fallen 16.2%, a trend that continued into this year with...

Canon Electronics (TSE:7739) reported a net profit margin of 6.6%, pulling back from 7.7% in the previous period, while earnings expanded at an average annual rate of 10.9% over the last five years. Despite a recent decline in earnings growth, the company’s high quality earnings, price-to-earnings ratio of 16.3x (below the peer average but above the industry), and share price of ¥2,753, which trades below its estimated fair value of ¥3,606.36, are drawing investors’ attention. As investors...

Bull-Dog Sauce (TSE:2804) posted an impressive 809.1% jump in yearly earnings, propelled by a one-off gain of ¥2.8 billion, which sent net profit margins soaring to 17.1% from last year’s 1.9%. Over the past five years, earnings have grown at an average pace of 14.1% per year, highlighting a trend of sustained profitability. While these headline results appear strong, it is clear that the most recent boost in net income reflects exceptional factors rather than ongoing business...

Shin-Etsu Chemical (TSE:4063) posted a net profit margin of 19.3%, down from last year’s 20.6%, with earnings expanding at an average rate of 8.9% per year over the past five years despite a recent dip in yearly earnings. Looking ahead, analysts expect annual earnings growth of 7.75% and revenue growth of 4.6% per year, just edging out the broader Japanese market’s 4.4% revenue forecast. Mixed signals in the data, with solid long-term performance but a slight squeeze on margins, have caught...

Chugai Pharmaceutical (TSE:4519) posted earnings growth of 2.6% in the last year and has grown at an average rate of 10.7% annually over the past five years. Its net profit margin eased slightly to 32.7% from last year’s 33.9%, while analysts expect revenue and earnings to keep moving ahead of local industry averages. As investors consider the company’s robust margins and projected above-market growth, recent moderation in growth rates and share price trends may play a key role in shaping...

Canon Marketing Japan (TSE:8060) reported revenue growth of 1.1% per year, trailing the broader Japanese market’s pace of 4.4%. Earnings are projected to grow at 4.7% annually, behind the national market’s expected 8%, with the company’s net profit margin steady at 5.9% compared to last year. Investors will note that while recent profit growth is positive at 5.3% compared to the five-year average of 10.2%, the latest figures point to more modest expansion ahead rather than a dramatic shift in...

ES-CON JAPAN (TSE:8892) posted a net profit margin of 9.8%, slightly topping last year's 9.2%. EPS growth came in at 20.4% for the period, well ahead of the company’s own five-year CAGR of 17%. With five years of steady 17% annual earnings growth and a new high-quality result in hand, investors have plenty to consider regarding what is driving this momentum. See our full analysis for ES-CON JAPAN. Next, we will look at how these headline numbers compare with the main narratives shaping...

Bernstein SocGen Group has downgraded Sumco (TSE:3436) from Market Perform to Underperform, even though the stock has rallied recently on excitement around AI. The change comes as concerns mount over slower wafer shipment growth, which is linked to high inventory and limited NAND wafer demand. See our latest analysis for Sumco. Sumco’s recent rally has turned heads, especially with a 47.92% year-to-date share price return and a one-year total shareholder return of 18.74%. While momentum has...

Kirin Holdings Company (TSE:2503) has attracted attention recently as investors revisit its stock performance and fundamentals. Over the past 3 months, shares have gained 11%, which has sparked interest in how its future prospects are shaping up. See our latest analysis for Kirin Holdings Company. The past year has been a mixed ride for Kirin Holdings Company, with its share price recently climbing 11% over the last three months. This increase suggests that investors may be warming up to its...

Mitsui Chemicals recently filed a shelf registration to issue up to ¥180 billion in bonds, signaling a significant capital-raising initiative. This move could reshape the company’s approach to funding new investments, affect its capital structure, and influence investor sentiment regarding its future growth strategies. We'll consider how such a substantial bond shelf registration could reshape Mitsui Chemicals’ investment case and longer-term capital allocation outlook. Find companies with...

JGC Holdings (TSE:1963) delivered flat revenue for the nine-month period but reported a steep 90% decline in gross profit along with an operating loss, prompting a significant downward revision to its full-year guidance. Management is rolling out a comprehensive overhaul to address costly project overruns and delayed investments. See our latest analysis for JGC Holdings. Amid headline-making challenges, JGC Holdings’ share price has actually climbed 21% year-to-date, with the total...

On October 14, 2025, Healios K.K. announced the termination of its business and capital alliance with Nikon Corporation, ending an agreement made in 2017 to advance regenerative medicine initiatives. This move signals a shift in both companies’ approaches, with each now aiming to independently expand their respective strengths in healthcare and life sciences. We’ll examine how Nikon’s decision to end its partnership with Healios and focus on its own healthcare strategies could influence its...

Recent analysis highlights JAPAN MATERIAL’s role as a critical supplier in the semiconductor industry, with the company set to gain from expected collaborations with Rapidus and TSMC’s Kumamoto plant. This positions JAPAN MATERIAL to potentially capture new opportunities as semiconductor supply chains expand to meet growing global demand. Let’s explore how JAPAN MATERIAL’s involvement with major semiconductor projects shapes its investment narrative and future growth prospects. These 15...

Shimadzu Corporation recently announced its aim to generate US$500 million annually from U.S.-developed products by 2035, highlighting an ambitious long-term revenue target for the North American market. This initiative reflects Shimadzu's increasing commitment to expanding its product footprint and innovation pipeline outside Japan, especially by leveraging U.S. market opportunities. We'll explore how Shimadzu's sharpened focus on U.S.-developed product growth could influence its broader...